{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:43Z","timestamp":1783098463161,"version":"3.54.6"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"DOI":"10.7759\/cureus.76739","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T16:49:46Z","timestamp":1735750186000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful Management of Rhino-Orbital Mucormycosis in a Diabetic Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Stanislav","family":"Tsisar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Salvado de Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gameiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-007-0066-4","article-title":"Zygomycosis: an emerging fungal infection with new options for management","volume":"9","author":"Kauffman CA","year":"2007","unstructured":"Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007, 9:435-40. 10.1007\/s11908-007-0066-4","journal-title":"Curr Infect Dis Rep"},{"key":"ref2","article-title":"Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum","volume":"241","author":"GA GR","year":"1961","unstructured":"GA GR, WE AM. Studies of opportunistic fungi. I. Inhibition of Rhizopus oryzae by human serum. Am J Med Sci. 1961, 241:604-12.","journal-title":"Am J Med Sci"},{"key":"ref3","unstructured":"Mucormycosis. (2024). Accessed. June 12, 2024: https:\/\/www.who.int\/india\/home\/emergencies\/coronavirus-disease-%28covid-19%29\/mucormycosis."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2021.5201","article-title":"Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India","volume":"140","author":"Choksi T","year":"2022","unstructured":"Choksi T, Agrawal A, Date P, et al.. Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India. JAMA Ophthalmol. 2022, 140:66-72. 10.1001\/jamaophthalmol.2021.5201","journal-title":"JAMA Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.156.3.337","article-title":"Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex","volume":"156","author":"Strasser MD","year":"1996","unstructured":"Strasser MD, Kennedy RJ, Adam RD. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch Intern Med. 1996, 156:337-9. 10.1001\/archinte.156.3.337","journal-title":"Arch Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis DP","year":"2011","unstructured":"Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood. 2011, 118:1216-24. 10.1182\/blood-2011-03-316430","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.10.142","article-title":"Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections","volume":"109","author":"Memar MY","year":"2019","unstructured":"Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019, 109:440-7. 10.1016\/j.biopha.2018.10.142","journal-title":"Biomed Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong W","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019, 25:26-34. 10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/332762-successful-management-of-rhino-orbital-mucormycosis-in-a-diabetic-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T16:49:48Z","timestamp":1735750188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/332762-successful-management-of-rhino-orbital-mucormycosis-in-a-diabetic-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.76739","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}